These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 32924723)

  • 21. Enzyme immunoassay for serum autoantibody to survivin and its findings in head-and-neck cancer patients.
    Chang JT; Wong FH; Liao CT; Chen IH; Wang HM; Cheng AJ
    Clin Chem; 2004 Jul; 50(7):1261-4. PubMed ID: 15229162
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC).
    Ebnoether E; Muller L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Head and Neck Tumors with Functional MR Imaging.
    Jansen JFA; Parra C; Lu Y; Shukla-Dave A
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):123-133. PubMed ID: 26613878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential allelic deletion of RBSP3, LIMD1 and CDC25A in head and neck squamous cell carcinoma: Implication in cancer screening and early detection.
    Sarkar S; Panda CK
    Cancer Biol Ther; 2018 Jul; 19(7):631-635. PubMed ID: 29624473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer.
    Keam B; Kim HR; Yun HJ
    Cancer Res Treat; 2019 Jan; 51(1):413-414. PubMed ID: 30064199
    [No Abstract]   [Full Text] [Related]  

  • 26. NMR spectroscopy evaluation of plasma "oncolipids" in head and neck cancer.
    Scher RL; Ropka ME; Neal DA; Berr S; Trouard T; Deutsch B; Cantrell RW; Levine PA
    Otolaryngol Head Neck Surg; 1990 Jan; 102(1):34-40. PubMed ID: 2106116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing.
    Lilja-Fischer JK; Saksø M; Stougaard M; Steiniche T; Overgaard J
    Acta Oncol; 2019 Oct; 58(10):1506-1508. PubMed ID: 31271080
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical studies in head and neck cancer.
    Lal H
    Clin Biochem; 1994 Aug; 27(4):235-43. PubMed ID: 8001283
    [No Abstract]   [Full Text] [Related]  

  • 29. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Head and Neck Cancers Be Detected with Mean Platelet Volume?
    Eryilmaz A; Basal Y; Omurlu IK
    Asian Pac J Cancer Prev; 2015; 16(16):7045-7. PubMed ID: 26514488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cell-free tumor DNA in molecular diagnostics of head and neck cancer].
    Oellerich M
    HNO; 2021 Apr; 69(4):324. PubMed ID: 33616678
    [No Abstract]   [Full Text] [Related]  

  • 32. Exosomes in head and neck cancer: Roles, mechanisms and applications.
    Cao J; Zhang M; Xie F; Lou J; Zhou X; Zhang L; Fang M; Zhou F
    Cancer Lett; 2020 Dec; 494():7-16. PubMed ID: 32781015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head and neck cancer--Part 2: Treatment and prognostic factors.
    Mehanna H; West CM; Nutting C; Paleri V
    BMJ; 2010 Sep; 341():c4690. PubMed ID: 20876637
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigation of urinary transforming growth factor alpha levels as tumor markers in patients with advanced squamous cell carcinoma of the head and neck.
    Fazekas-May M; Suen JY; Yeh YC; Yeh HW; Milligan LB
    Head Neck; 1990; 12(5):411-6. PubMed ID: 2211102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates on Immunohistochemical and Molecular Markers in Selected Head and Neck Diagnostic Problems.
    Yi CH; Jim Zhai Q; Wang BY
    Arch Pathol Lab Med; 2017 Sep; 141(9):1214-1235. PubMed ID: 28854343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring.
    Diez-Fraile A; Ceulaer J; Derpoorter C; Spaas C; Backer T; Lamoral P; Abeloos J; Lammens T
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
    Wang Y; Wang J; Huang Y
    Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.
    Mes SW; Leemans CR; Brakenhoff RH
    Expert Rev Mol Diagn; 2016; 16(2):205-21. PubMed ID: 26620464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Head and Neck Cancer - New Insights into a Heterogeneous Disease.
    Klussmann JP
    Oncol Res Treat; 2017; 40(6):318-319. PubMed ID: 28521323
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer.
    Prasanna R; Balan A; Radhakrishna Pillai M
    Oral Oncol; 2015 Nov; 51(11):e86. PubMed ID: 26410022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.